
The US Food and Drug Administration (FDA) has recalled 89,592 bottles of children's ibuprofen sold nationwide after consumers reported finding black particles and a gel-like mass inside the liquid medication, raising alarm among parents who rely on the drug for their children's fevers and pain relief.
The voluntary recall was initiated on 2 March by Strides Pharma Inc., an India-headquartered pharmaceutical manufacturer with US operations in Bridgewater, New Jersey. But the FDA didn't formally classify the recall until 16 March, a two-week gap that left parents without a clear picture of the risk level during a critical window.